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Abstract
As a cell source, multipotent mesenchymal stromal cells or 
mesenchymal stem cells (MSCs) are promising candidates 
for chondrogenic differentiation and subsequent cartilage 
regeneration. From previous literature, it is known that 
chondrogenic differentiation of MSCs inevitably leads to 
hypertrophy and subsequent endochondral ossification. In 
this review, we examine the history of currently established 
protocols of chondrogenic differentiation and elaborate 
on the roles of individual components of chondrogenic 
differentiation medium. We also summarise the effects 
of physical, chemical and biological factors involved, 
and propose potential strategies to differentiate MSCs 
into articular chondrocytes with homogenous mature 
phenotypes through spatial-temporal incorporation of cell 
differentiation and chondrogenesis.
Keywords: Chondrogenic differentiation, chondrogenesis, 
mesenchymal stem cells, chondrocytes, chondrogenic 
differentiation factors.
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Articular cartilage is an avascular connective tissue 
with limited capacity for self-regeneration. Injury and 
degeneration of cartilage have far-reaching impacts 
on personal life, healthcare expenses and reduced 
productivity in the work force (Ge et al., 2006). 
Current clinical treatment strategies, such as autologous 
chondrocyte implantation, bone marrow stimulation 
and mosaicplasty, have varying success rates, but their 
long-term results are far from satisfactory due to the lack 
of structural organisation of articular cartilage, as well 
as inferior mechanical properties of the newly formed 
tissue (Hunziker, 2009). Cartilage tissue engineering 
has the potential to create a more durable and functional 
replacement for the degenerated tissue; chondrocytes 
and stem cells are two promising cell source candidates 
for this replacement tissue. Chondrocytes are potentially 
the ideal seed cells with mature and stable phenotype as 
well as lineage stability. However, they are limited by 
scarcity during harvest and dedifferentiation during in 
vitro proliferation (Kock et al., 2012). Establishment of 
embryonic stem cells (ESCs) requires embryos, which 
leads to ethical issues for clinical applications. Induced 
pluripotent stem cell (iPSC) technology can provide 
patient-specific cells, but uncontrolled and unexpected 
differentiation limits their application (Blin et al., 2010; 
Yoshida and Yamanaka, 2010). Multipotent mesenchymal 
stromal cells or mesenchymal stem cells (MSCs) are a 
broadly adopted cell source for cartilage regeneration due to 
ample availability from multiple tissues, high proliferation 
capacity and the ability to differentiate into chondrocytes 
(Derfoul et al., 2006; Kassis et al., 2006). However, 
concomitant premature phenotypes of the differentiated 
chondrocytes, undesirable hypertrophic differentiation 
(Studer et al., 2012), lack of subtype phenotypes and 
subsequent immature extracellular matrix (ECM) under 
current chondrogenic differentiation protocols have 
hindered the clinical application of stem cell-differentiated 
chondrocytes (Huey et al., 2012; Mueller and Tuan, 2008).
 Weighing the advantages and disadvantages of candidate 
cell sources, apart from using chondrocytes, MSCs may be 
the most adaptive cell source for current clinical use and for 
cartilage tissue engineering applications. Therefore, finding 
ways to improve in vitro chondrogenic differentiation of 
MSCs may be the next primary focus of tissue engineering 
research, which is somewhat different with the well-
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orchestrated embryonic chondrogenic differentiation 
process of MSCs. Embryonic chondrogenesis have been 
reviewed extensively with the focus on mesenchymal cell 
condensation, chondroprogenitor cells, chondrocytes as 
well as related mediators (Goldring et al., 2006). Apart 
from embryonic chondrogenesis, joint specification and 
postnatal development have also been reviewed, though 
many questions remain unexplored (Onyekwelu et al., 
2009). MSCs have been well studied, regarding their 
definition, tissue origins, chemokines and receptors, as 
well as their in vivo microenvironments (Augello et al., 
2010); key factors like cell metabolic activity and transcript 
levels important for functional MSC-derived cartilage 
regeneration are summarised elsewhere (Chen et al., 2006). 
Based on all these progresses, we summarise the history 
and challenges faced by current broadly used chondrogenic 
differentiation protocols with an aim to shed valuable 
light on the potential novel strategies to circumvent 
the challenges faced, which may benefit bioengineers 
and researchers in the field of tissue engineering and 
regenerative medicine.
Chondrogenic differentiation into articular 
chondrocytes
Chondrogenesis is initiated by cell condensation during 
embryonic development, before the mesenchymal 
stem cells differentiate into multiple lineages, such as 
articular, growth plate, intervertebral disc chondrocytes 
or endochondral ossification [some of the cells survive 
and transform into osteoblasts (Zhang et al., 2014)]. For 
years, mesoderm was thought to be the origin of MSCs; 
however, new evidence indicates that the neuroepithelium, 
including the neural crest, may also be an early origin 
of MSCs (Morikawa et al., 2009; Takashima et al., 
2007). MSCs from the somatopleure of the lateral plate 
mesoderm, neural crest cells in the neural ectoderm and 
sclerotome compartment of the paraxial mesoderm or 
somite differentiate into chondrogenic lineages and then 
yield the limbs, craniofacial bones and axial skeleton 
separately (Goldring et al., 2006; Olsen et al., 2000). 
Chondrogenesis may occur in one of two directions in the 
developing bone. One leads to the formation of bone via 
endochondral ossification, (at the primary and secondary 
centres of ossification, and in the growth plate) and the 
other leads to stable hyaline articular cartilage. The growth 
plate is composed of the resting zone, proliferative zone 
and hypertrophic zone (Abad et al., 2002). Growth plate 
cartilage progresses to form the bone (Mackie et al., 
2008), whereas the articular cartilage does not (Pacifici 
et al., 2005). Chondrocytes of the presumptive articular 
surface arise directly from a subpopulation of early 
chondroprogenitor cells, expressing doublecortin and 
growth/differentiation factor-5 (GDF-5) (Koyama et al., 
2008; Zhang et al., 2007), but not matrilin-1 (Hyde et al., 
2007). Articular chondrocytes maintain the phenotype 
instead of resorting to hypertrophy by maintaining high 
expression of ACAN and PRG4 (lubricin gene) and low 
expression of COL2A1 with low proliferation (Lefebvre 
and Smits, 2005).
 While articular cartilage at birth undergoes ossification 
and mineralisation, appositional growth from the surface 
forms an adult articular cartilage until puberty (Hunziker 
et al., 2007; Onyekwelu et al., 2009). These slowly 
dividing stem cells have bidirectional mitotic activity. In 
the horizontal direction, they furnish new stem cells that 
replenish the pool and contribute to the lateral expansion 
of the articular cartilage layer. In the vertical direction, 
the superficial zone supplies the rapidly dividing, transit-
amplifying daughter-cell pool that feeds the transitional 
and upper radial zones and gradually forms the layered 
structure (Hunziker et al., 2007). This growth activity of 
the articular surface ceases at puberty, whereas expansion 
of the metaphyseal growth plate continues until the time 
of skeletal maturity (Clark et al., 1997; Hunziker et al., 
2007). Knowledge derived from endochondral ossification 
has been largely used to establish current chondrogenic 
differentiation protocols, while growth plate chondrocytes 
that are easily accessible sources are often compared to 
articular chondrocytes (Iwamoto et al., 2013; Leijten et 
al., 2012) (Fig. 1).
A history of the understanding of chondrogenic 
differentiation
Studies of the embryonic development of cartilage or 
cartilaginous tissues started as early as the 1960s. Ectopic 
implantation was a major research model during this 
period. The somites, which are embryonic cartilaginous 
progenitor cells, differentiated into chondrocytes in vitro 
when co-cultured with notochords (Lash et al., 1960). 
Holtzer observed chondrogenesis of somites occurring 
in the presence of neural tubes (Holtzer, 1952; Holtzer 
and Detwiler, 1953). A fraction obtained from a cold 
perchloric acid extract of spinal cord and notochord was 
able to induce chondrogenesis (Lash et al., 1962), which 
contained chondrogenic factors consisting of polypeptides, 
nucleotides and sugars (Holtzer, 1964; Hommes et al., 
1962). De-differentiation of chondrocytes was reported 
with morphological changes from spherical to stellate 
coupled with decreased synthesis of chondroitin sulphate 
and enhanced cell proliferation (Abbott and Holtzer, 1966). 
These findings led to the establishment of the pellet culture 
system, now broadly used in chondrogenic differentiation 
(Hattori and Ide, 1984).
 In the 1970s and 1980s, laboratory studies evaluating 
the effect of cell shape, cell-cell and cell-matrix interactions 
on chondrogenesis were undertaken. Chondrocytes 
with spherical morphologies synthesised higher levels 
of chondroitin sulphate in comparison to those with 
spindle-like morphologies (Archer et al., 1982). Cell-
cell interactions, including both interactions amongst 
limb bud mesenchyme cells (Owens and Solursh, 1982) 
and epithelial-mesenchymal cells (Sanders, 1988), are 
essential for the differentiation of prechondrogenic limb 
mesenchyme into cartilage. Gene expression of both COL 
I and fibronectin increased at the onset of condensation, 
reached the highest point of chondrogenic differentiation 
and then subsided and were replaced with elevated 
COL2A1 expression (Dessau et al., 1980; Kulyk et al., 
14 www.ecmjournal.org
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1989). Furthermore, in the 1980s, transforming growth 
factor-β (TGF-β) was identified as a key cartilage-inducing 
factor (Heine et al., 1987; Seyedin et al., 1986).
 Many components play supplementary roles in 
the current chondrogenic differentiation medium. For 
instance, ascorbate stabilises the triple helical structures 
of collagen through hydroxylation of proline residues 
in procollagen and hydroxyproline (Peterkofsky, 1972). 
Serum inhibits the production of cartilage matrix during 
in vitro chondrogenesis of limb bud mesodermal cells of 
chick embryos (Hattori and Ide, 1984), whereas serum-
free medium containing insulin/transferrin/selenium (ITS) 
successfully keeps cells alive and active (Bottenstein and 
Sato, 1979).
 The current broadly-used chondrogenic differentiation 
medium was established in the 1990s, with the presence 
of TGF-β in pellet cultures (Johnstone et al., 1998). This 
chondrogenic differentiation medium includes TGF-β, 
ITS, high-glucose, dexamethasone (Dex), ascorbic acid, 
sodium pyruvate and proline, but lacks serum (Johnstone 
et al., 1998; Vater et al., 2011) (Table 1). High-glucose 
was found to promote MSC survival and protect cells from 
apoptosis by altering the metabolism of the cells in pellet 
cultures and increasing the synthesis of proteoglycans 
through respiratory repression (Crabtree effect) (Mackay 
et al., 1998).
 The functions and mechanisms of differentiation-
related growth factors, such as bone morphogenetic 
protein (BMP), fibroblast growth factor (FGF), parathyroid 
hormone related protein (PTHrP) and Indian hedgehog 
(IHh), were studied in depth during this period (Murtaugh 
et al., 1999; Shukunami et al., 1996). Though these 
growth factors can benefit chondrogenesis in vitro, they 
are not routinely included in the current medium due to 
several limitations. BMPs have been shown to promote 
the expression of SOX9 and COL II, however, they also 
inevitably result in a hypertrophic phenotype of cells 
(Enomoto-Iwamoto et al., 1998; Nonaka et al., 1999). 
FGFs can maintain the proliferation of cells but result in 
chondrodysplasia when overexpressed (Minowada et al., 
1999). Additionally, PTHrP can reverse chondrocytes from 
a hypertrophic phenotype to a prehypertrophic proliferating 
phenotype, and prevent terminal differentiation of 
chondrocytes in vitro (Zerega et al., 1999). IHh expressed 
in prehypertrophic chondrocytes enhances hypertrophic 
differentiation. Misexpression of IHh can prevent 
hypertrophic differentiation of chondrocytes (Vortkamp 
A, 1996).
 In the late 1990s, the role of integrins in mediating 
cell attachment to extracellular matrix proteins was 
highlighted. These interactions regulated morphogenesis 
and cell differentiation. Treatment with integrin β1 
antibodies inhibited early chondrogenesis of limb bud 
cells from mouse embryos in vitro (Shakibaei, 1998). 
Additionally, SOX9 was found to be a master gene which 
regulated downstream COL2A1 expression directly (Healy 
et al., 1999).
 Understanding of chondrogenic differentiation has 
accelerated since the year 2000, attributed to the application 
of a variety of genetic modification techniques. Epigenetics 
then emerged as an important field. MicroRNAs (miRNAs) 
proved effective mediators of key pathways during 
MSC differentiation through regulating transcription 
factors (Hong and Reddi, 2012). DNA methylation and 
histone modification (including histone acetylation and 
deacetylation) are involved in chondrogenesis through 
modulating chromatin structures, which directly influence 
the activity of DNA in transcription, replication and 
Fig. 1. A schematic representation of different stages of chondrogenesis and endochondral ossification. The 
development of cartilage starts with MSC condensation. After committing to chondrogenesis, cells follow one of 
two different directions in the developing bone. One leads to the formation of bone via endochondral ossification 
(at the primary ossification centre (POC), secondary ossification centre (SOC), and in the growth plate) (the process 
marked in black) and the other that leads to stable hyaline articular cartilage. All committed hyaline chondrocytes 
start expressing COL2A1; matrilin-1 expression by cells arising from the interzones that are destined to become 
growth plate chondrocytes distinguishes them from articular chondrocytes. Doublecortin and GDF-5 only express in 
the articular cartilage. Most embryonic articular cartilage present at the ends of the bone at birth is replaced by bone 
and new cartilage formed by stem cells in the superficial zone. Articular cartilage becomes fully mature in adulthood. 
With the disappearance of growth plate cartilage, the SOC connects with the POC and gradually disappears in mature 
mammals. Stem-like cells exist in the cell condensation stage, keep stemness in the superficial zone of AC from birth 
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Table 1. Chondrogenic differentiation medium and effects of individual components on chondrogenesis





(Johnstone et al., 1998; 
Vater et al., 2011)
TGF-β (J.Zuscik et 
al., 2004; Lutz and 
Knaus, 2002; Park et 









β-catenin, Smad 10 ng/mL 
IGF-I, BMPs, 
PHTrP 
TGF-β1, β2 and β3, have similar 
functions
Insulin (Mueller et al., 






kinase activity of 
the insulin receptor 
1-10 μg/mL Transferrin, selenium
Transferrin (Cigan, 
2013; Kisiday et al., 
2005)
Iron-binding 1-30 μg/mL Insulin, selenium
Selenium (Yan et al., 
2012) 
Anti-oxidant and 
enhances proliferation 5 μg/mL 
Insulin, 
transferrin
Dex (M.Florine et 
al., 2013; Thomas 
M.Randua, 2013)
Supports cell viability 
and delays the 
appearance of type X 
collagen 
GRs, Scrapie 
Responsive Gene 1 10
-7 M TGF-β
Glucose (Cigan, 2013; 








Ascorbic acid (Choi et 
al., 2008; Franceschi, 
1992; Peterkofsky, 






Reduction of iron 
to its ferrous state 50 mg/mL Proline
L-ascorbate, sodium L-ascorbate, 
and L-ascorbate-2-phosphate
Pyruvate (Andrae et 








1972; Washington et 
al., 2010)
Stabilisation of 




pathway 40 μg/mL Ascorbic acid
Selected growth 
factors regulators
BMPs (Cao and Chen, 
2005; Hassel et al., 
2003; Hatakeyama 
et al., 2004; Jin et 
al., 2006; Sekiya et 





Smad 10-500 ng/mL TGF-β
BMP-2, enhances proliferation and 
ECM, and downregulates Col I 
expression.
BMP-4, accelerates the progression 
of cartilage differentiation to 
maturation
BMP-6, enhances chondrogenesis 
in special subpopulation of MSCs, 
increases proteoglycans
BMP-7, inhibits cell proliferation, 
induces chondrogenic 
differentiation
BMP-9, enhances Sox9, Col2A1 
and aggrecan, overcome the 
inhibitory effect of IL-1.
GDF-6(BMP-13), inhibits 
hypertrophic chondrocyte specific 
marker, upregulate of proteoglycan
GDF-5(BMP-14) 
(Coleman and Tuan, 










150 ng/mL TGF-β, BMP 
PHTrP (Barbara 
Zerega, 1999; Kim et 





PTHrP and IHH 
feedback loop 10 μM TGF-β PHTrP1-34
FGF (Ng et al., 2008; 
Solchaga et al., 2005; 












FGF-2, increases proliferation, and 
proteoglycan production
FGF-18, inhibits cell proliferation 
and induces chondrogenic 
differentiation
recombination (Furumatsu and Ozaki, 2010; Roth et 
al., 2001). Recently, several groups found an important 
relationship between epigenetic marking and gene 
expression in chondrogenesis. Herlofsen et al. found that 
modifications can provide primary epigenetic control of 
the early differentiation of MSCs toward the chondrogenic 
lineage (Herlofsen et al., 2013).
 Biophysical, chemical and mechanical factors were 
found to be heavily involved in chondrogenesis (Leijten et 
al., 2014). Small chemical molecules (Benoit et al., 2008), 
matrix elasticity (Engler et al., 2006; Park et al., 2011), cell 
material property (cell softness) (Chowdhury et al., 2010) 
and many more factors, are now known to guide MSCs 
to differentiate into specific cell lineages. A breakthrough 
in the regeneration of articular cartilage illustrated that an 
entire articular surface can be regenerated using adult stem/
progenitor cells recruited from the host with the help of 
biomaterial-based scaffold and growth factors (Lee et al., 
2010).
Key elements in current chondrogenic differentiation 
medium
At present, MSCs cultured in pellet and micromass systems 
in the presence of chondrogenic differentiation medium 
are the two major methods for initiating chondrogenic 
differentiation in vitro. The following sections will describe 
16 www.ecmjournal.org
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the in-depth role of the ingredients potentially used in 
chondrogenic differentiation medium.
 TGF-β is the core component in most chondrogenic 
differentiation protocols used currently. TGF-βs exist in 
three homologous homodimeric forms (β1, β2 and β3) 
and all of them signal through the same receptors [TGF-β 
receptor I (TGF-β RI) and II (TGF-β RII)]. After activation 
of the TGF-β receptors, TGF-β induces chondrogenesis 
mainly through TGF-β/drosophila mothers against 
decapentaplegic protein (Smad) and mitogen-activated 
protein kinase (MAPK) signalling pathways, that cross-talk 
with each other (Li et al., 2010; Lutz and Knaus, 2002; 
Schmierer and Hill, 2007) (Fig. 2). Before phosphorylation 
by TGF-β RII, TGF-β RI is catalytically inactive due to 
a wedge-shaped GS region (a highly conserved 30-amino 
acid region with a characteristic SGSGSG sequence) 
inserted into the kinase domain (Massagué, 1998). In Smad 
signalling, TGF-β RII phosphorylates the GS region after 
forming a ligand-receptor complex with TGF-β, which 
results in the activation of TGF-β RI (Huse et al., 1999). 
The activated TGF-β RI phosphorylates Smad2/3, which 
recruits Smad4, and the complex translocates into the 
nucleus (Massagué and Wotton, 2000). The translocated 
Smad2/3 associates with Sox9 and CBP/p300 (cAMP-
response element-binding protein, which has an intrinsic 
histone acetyltransferase activity and acts as an important 
co-activator for the expression of the COL2A1) on the 
COL II enhancer region containing the Sox9-binding 
site that is important for the initiation of chondrogenic 
differentiation (Furumatsu et al., 2005). As for MAPK 
signalling, the major subtypes of MAPK include p38, 
extracellular signal-regulated kinase-1 (ERK-1) and c-jun 
N-terminal kinase (JNK). In addition, p38 is an enhancer 
of chondrogenesis, whereas ERK-1 is a repressor of 
chondrogenesis; JNK plays a minor role in chondrogenesis. 
Activation of MAPK involves indirect modulation of cell 
adhesion molecules, including N-cadherin and integrin 
α5β1, during precartilage condensation and progression 
to chondrogenic differentiation (Tuli et al., 2003). TGF-β 
induces the expression of the chondrogenic factor SOX9 
and the function of the main chondrogenic trio (SOX5, 
SOX6 and SOX9) (Lefebvre et al., 1998; Lefebvre 
and Smits, 2005) that further regulates chondrogenic 
differentiation and ECM formation. It is known that the 
genes for many ECM components, such as ACAN, COL2A1 
and Matrilin-1, are only expressed when the three Sox 
proteins bind to the high-mobility group (HMG)-domain 
sites in their enhancers (Akiyama and Lefebvre, 2011). 
On the contrary, TGF-β also plays an inhibitory role in 
chondrocyte maturation (Ballock et al., 1993; Kato et al., 
1988; Serra et al., 1997).
 ITS premix is a substitute for foetal bovine serum 
that maintains cellular activity in biosynthesis and cell 
division. Serum has some disadvantages including poor 
characterisation and inconsistency in batch-to-batch 
composition and quality (Barnes and Sato, 1980; Cigan, 
2013). Insulin is a primary factor involved in the onset 
and progression of chondrogenesis (Quarto et al., 1992) 
and can facilitate chondrogenesis in a dose-dependent 
manner (1-10 μg/mL) with added TGF-β (Mueller et al., 
Fig. 2. TGF-β and MAPK 
signalling in chondrogenic 
differentiation of MSCs.
17 www.ecmjournal.org
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2013a). Furthermore, insulin can facilitate glucose uptake 
(Kono et al., 1982) and enhance DNA synthesis and 
proteoglycan production in cartilage cultures (Maor et al., 
1993; Rosen, 1987). Transferrin promotes cell proliferation 
and differentiation through detoxifying oxygen radicals 
and peroxides (Ned et al., 2003; Schäfer et al., 2007). 
Selenite, a co-factor for glutathione peroxidase and other 
proteins, enhances proliferation of chondrocytes through 
acceleration of G1-phase cell cycle progression and the 
induction of cyclin D1 (Wei et al., 1986). This effect is 
mediated by the enhancement of intracellular adenosine 
triphosphate (ATP) content (Yan et al., 2012).
 Dex, a synthetic glucocorticoid, promotes chondrogenic 
differentiation through enhancing related gene expression 
(Florine et al., 2013; Jakobsen et al., 2014; Randua et al., 
2013). The chondrogenic effects of glucocorticoids are 
predominantly mediated via the glucocorticoid receptors 
(GRs). GRα constitutes the main active GR form while 
GRβ constitutes a negative isoform of GRα (Oakley et 
al., 1999). Dex promotes chondrogenic differentiation by 
down-regulating GRβ levels and maintaining GRα levels 
(Derfoul et al., 2006). Dex enhances the gene expression 
of COL XI under chondrogenic conditions (collagen XI 
acts as both the template for collagen II fibrillogenesis and 
a regulator for maintaining fibril diameters in cartilage) 
(Chen et al., 2005; Derfoul et al., 2006). Previous studies 
have shown that Dex enhanced the TGF-β induced 
expression of ACAN, COL2A1 and cartilage oligomeric 
matrix protein (COMP) and supported cell viability, as 
well as delayed the expression of COL X when used in 
conjunction with TGF-β (Derfoul et al., 2006; Quarto et al., 
1992). The tissue origin of MSCs determines the effect of 
Dex on chondrogenic differentiation. Dex enhanced TGF-
β1-induced chondrogenesis in bone marrow-derived MSCs 
(BMSCs) but had no significant impact on the TGF-β1- or 
BMP2-induced response in synovial derived MSCs (Kurth 
et al., 2007; Park et al., 2005; Shintani and Hunziker, 2011; 
Shintani et al., 2007). This may be due to the different 
cell survival rates and microenvironment which could be 
tissue-source dependent (Buxton et al., 2011).
 Glucose, a major energy source and precursor of 
ECM for most mammalian cells, promotes chondrogenic 
differentiation and inhibits apoptosis at high levels 
(4.5 g/L or 25 mM) (Mackay et al., 1998; Shikhman 
et al., 2001; Tsai et al., 2013). Glucose participates in 
multiple metabolic cycles of MSCs during chondrogenic 
differentiation, including oxygen consumption, glucose 
consumption and lactate production. High levels of 
glucose in the medium enhance cell differentiation 
by changing the metabolic patterns and modulating 
subsequent cell signalling pathways. The synthesis of 
proteoglycans increases through progressively inhibiting 
the respiration of chondrocytes cultured in vitro, as the 
glucose concentrations (1-10 mM) increase (Derfoul et 
al., 2006; Otte, 1991). High doses of glucose enhance the 
differentiation of stem cells into chondrogenic lineages 
through the down-regulation of ERK and protein kinase C α 
(PKCα) activities, up-regulation of p38, as well as through 
modulating the expression of adhesion molecules such as 
fibronectin, integrin β1 and N-cadherin (Han et al., 2004).
 Both ascorbic acid and proline are essential for the 
production of collagen in cartilage. Ascorbic acid enhances 
cell proliferation, synthesis and extracellular deposition of 
collagenous matrix, in particular collagen I and II (Choi 
et al., 2008; Franceschi, 1992; Potdar and D’Souza, 2010; 
Stone and Meister, 1962). Ascorbic acid stabilises the 
collagen triple helical structure through reduction of iron 
to its ferrous state, which is important for the hydroxylation 
of proline residues in procollagen and hydroxyproline and 
the maturation of protocollagen to collagen (Padh, 1991; 
Peterkofsky, 1991). Proline has been shown to regulate 
ESC differentiation into early primitive ectoderm-like 
(EPL) cells, through mammalian targeting of the rapamycin 
(mTOR) signalling pathway (Washington et al., 2010).
 Sodium pyruvate is essential for enhancing the energy 
metabolism in the Krebs cycle (Geshi et al., 2000). 
Mammalian cells secrete pyruvate and α-ketoacids in 
culture to protect them against hydrogen peroxide-induced 
cytotoxicity (Andrae et al., 1985; O’Donnell-Tormey 
et al., 1987). Pyruvate up-regulates the expression 
of genes involved in free radical scavenging which, 
in turn, enhances the antioxidative machinery and is 
essential for maintaining mitochondrial activity. Super-
physiological concentrations of pyruvate (50 mM, 50 folds 
of physiological concentrations) enhance mitochondrial 
mass and functionality (Wilson et al., 2007).
 Phenol red, a commonly used pH indicator in tissue 
culture medium can inhibit the chondrogenic differentiation 
of MSCs (Lysdahl et al., 2013). During chondrogenic 
differentiation, phenol red in Dulbecco’s Modified Eagle 
Medium (DMEM) has been shown to decrease SOX9, 
COL2A1 and ACAN on days 14 and 21 and proteoglycan 
synthesis on days 21 and 28 in culture (Lysdahl et al., 
2013). This phenomenon may have occurred due to 
phenol red’s structural resemblance to certain nonsteroidal 
oestrogens and weak oestrogen agonist activity (Berthois 
et al., 1986).
 BMPs are morphogens in the TGF-β superfamily and 
regulate chondrogenesis and skeletogenesis during normal 
embryonic development (Hogan, 1996). They are involved 
in various stages of chondrogenic differentiation, from 
initiation of chondrogenic differentiation, to regulation 
of chondrocyte maturation and terminal differentiation 
(Pizette and Niswander, 2000). BMP2, BMP4, BMP6 
and BMP7 are the most commonly used BMPs for 
chondrogenic differentiation (Kramer et al., 2000; Sekiya 
et al., 2005; Shen et al., 2010). BMPs signal through Smad 
or non-Smad signalling pathways. The Smad1/5/8 route 
is an important Smad-dependent pathway that induces 
hypertrophy and bone formation (Cao and Chen, 2005). 
The alternative Smad-independent pathway in BMP 
regulates chondrogenesis, mediated by activating several 
MAPKs including ERKs and p38 kinases (Hassel et al., 
2003). p38 enhances chondrogenesis by up-regulating 
SOX9 expression directly or by inhibiting the Wnt7a/
beta catenin pathway indirectly (Jin et al., 2006). MSCs 
from different species and tissue sources vary in their 
responsiveness to BMPs, partly due to their distinct cell 
receptor repertoires (Hennig et al., 2007; Osyczka et al., 
2004).
 GDF5, also known as BMP14 in humans, is a 
member of the TGF-β superfamily and plays an important 
18 www.ecmjournal.org
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role in limb bud mesenchymal cell condensation and 
chondrogenesis during embryogenesis (Coleman and Tuan, 
2003; Storm et al., 1994). GDF5 stimulates the recruitment 
and differentiation of chondrogenic cells at early stages 
and increases chondroprogenitor cell condensation and 
cartilaginous nodules without altering the overall pattern 
of differentiation. It causes a more sustained elevated 
expression level of SOX9 than BMP4 (Hatakeyama et al., 
2004). GDF5 increases mesenchymal cell condensation 
independent of cell density or N-cadherin-mediated 
adhesion and signalling; however, it is dependent on gap 
junction-mediated cellular communication (Coleman 
and Tuan, 2003; Sun et al., 2012). GDF5 can promote 
chondrogenesis via signalling cross-talk, when used 
together with TGF-β3 and BMP2 in vitro (Murphy et 
al., 2015). GDF5 has also been shown to increase the 
expression of COL2A1 and hypertrophic marker, alkaline 
phosphatase (ALP) by enhancing the phosphorylation of 
Smad1/5/8 (Coleman et al., 2013), which is activated by 
BMPs. GDF5’s effect on the enhancement of ACAN and the 
inhibition of MMP13 expression occurs by up-regulating 
the canonical Wnt inhibitors DKK1 (Enochson et al., 
2014).
 PTHrP inhibits TGF-β-induced hypertrophic 
differentiation by up-regulating the chondrogenic 
markers COL2A1 and SOX9 and down-regulating the 
hypertrophic markers COL10A1 and RUNX2 during in 
vitro chondrogenesis of MSCs (Kim et al., 2008; Weiss et 
al., 2010). PTHrP exerts its effects in vivo via the PTHrP 
and IHh feedback loop by binding to its receptor (PTHR1) 
and activating a range of signalling molecules, e.g. protein 
kinase A (PKA), PKC and inositol 1, 4, 5-tris-phosphate 
(IP3). Some signalling molecules act as negative regulators 
for IHh. Hence, PTHrP inhibits the terminal differentiation 
of chondrocytes driven by IHh (Kim et al., 2008; Mau et 
al., 2007; Rabie et al., 2003). The chondrogenic effects 
of PTHrP vary amongst different PTHrP isoforms. PTHrP 
1-34, added in chondrogenic medium containing TGF-β3, 
significantly increases chondrogenic differentiation with 
less hypertrophic differentiation, while other isoforms 
(PTHrP 1-86, 7-34 and 107-139) show inconsistent 
effects (Lee and Im, 2012). When culturing MSC pellets 
under hypertrophy-enhancing conditions [hypertrophy-
enhancing medium consisting of DMEM, 1 % ITS, 50 μg/
mL ascorbate-2-phosphate, 40 μg/mL L-proline and 1 nM 
triiodothyronine (T3)], adding PTHrP (1-40) does not 
diminish the induced enhancement of hypertrophy (Mueller 
et al., 2013b).
 The FGF family, especially FGF [basic FGF (bFGF); 
also known as FGF2], can maintain MSCs in an immature 
state during in vitro expansion and enhance MSC 
proliferation and differentiation potential (Mastrogiacomo 
et al., 2001; Solchaga et al., 2005; Tsutsumi et al., 2001). 
Literature suggests that aggregates of human MSCs that 
were expanded in culture in the presence of bFGF lacked 
the collagen I-positive and collagen II-negative outer layer 
characteristics of aggregates (Ng et al., 2008; Solchaga 
et al., 2005). However, in pellet cultures, the prolonged 
exposure of MSCs to bFGF caused the reduction of 
glycosaminoglycan (GAG) production (Hellingman et al., 
2010). Therefore, bFGFs can be added into the medium to 
culture MSCs, but in differentiation medium, it may not 
be necessary.
Physical, chemical and biological factors
In addition to biochemical molecules used in current 
chondrogenic differentiation medium, many other factors 
are involved in chondrogenic differentiation. These 
factors include physical (oxygen tension, mechanical, 
topography, etc.), chemical (small molecules, chemical 
properties, etc.) and biological factors (gene modification, 
bioactivity, epigenetics, etc.). Apart from biochemical 
factors (growth factors), biophysical factors (co-culture) 
and biophysicochemical factors (biomaterials) are equally 
important (Fig. 3). The influence of biophysical factors on 
chondrogenesis in vivo and in vitro have been reviewed 
(Huang et al., 2010a; Studer et al., 2012; Tate et al., 2008). 
In this section, we focus on the use of biophysical and 
biochemical cues for chondrogenesis and recent advances 
in the field of tissue engineering.
 Hypoxia can facilitate chondrogenic differentiation 
of MSCs, in addition to maintaining an undifferentiated 
state and inducing apoptosis. The microenvironment or the 
niche of MSCs in the bone marrow has low oxygen tension 
(˂ 32 mm Hg, 4.2 % oxygen) (Oze et al., 2012; Spencer 
et al., 2014). Therefore, chondrogenic differentiation 
is enhanced when MSCs are cultured in hypoxia (5 % 
oxygen) in comparison to normoxia (20 % oxygen) 
(Lee et al., 2013). Hypoxia has a positive influence on 
chondrogenic differentiation of MSCs, mainly through 
phosphorylation of AKT (known as protein kinase B) and 
p38 MAPK, thereby down-regulating hypoxia-inducible 
factor (HIF-1) (Kanichai et al., 2008).
 Mechanical stimulation can directly influence the fate of 
undifferentiated stem cells (Estes et al., 2004) via cellular 
and nuclear deformation and indirect biophysical factors, 
including osmotic and hydrostatic pressure and fluid 
flow (O’Conor et al., 2013). Matrix elasticity directs the 
differentiation of stem cells; soft matrix (~ 1 kPa) has been 
shown to promote MSC differentiation into a chondrogenic 
lineage (Engler et al., 2006; Park et al., 2011), while 
activation and internalisation of integrin are actively 
involved in the regulation of stem cell differentiation (Du 
et al., 2011). Cell-material properties, such as cell stiffness, 
dictate cell spreading and alter differentiation in response 
to physical stimuli (Chowdhury et al., 2010). Surface 
topography can trigger changes in MSC morphology, gene 
expression and cytoskeletal structure (Huang et al., 2010b). 
Compared to non-patterned surfaces, nano-pillar and 
nano-hole topographies enhanced MSC chondrogenesis 
and facilitated hyaline cartilage formation, whereas nano-
grill topography delayed chondrogenesis and induced the 
formation of fibro/superficial zone cartilage (Wu et al., 
2014).
 Small chemical molecules are also known to guide MSC 
differentiation (Benoit et al., 2008) by binding to specific 
receptors that promote chondrogenic differentiation 
(Cho et al., 2012; Johnson et al., 2012; Kafienah et al., 
2007; Schugar et al., 2008). As an illustrative example, 
kartogenin (KGN) has been shown to encourage 
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Fig. 3. Factors in the process of in vitro chondrogenic differentiation in MSCs.
chondrogenic differentiation of human MSCs, by 
significantly enhancing the expression of COL2A1, SOX9 
and ACAN. However, KGN had no significant effect on the 
gene products associated with chondrocyte calcification, 
such as osteocalcin (OCN), ALP and COL10A1, in human 
MSCs or chondrocytes (Johnson et al., 2012). KGN 
functions by binding to filamin A, an actin-binding protein 
that cross-links actin filaments. Thereby, by regulating the 
cytoskeletal network organisation and dynamics (Gorlin et 
al., 1990) and disrupting its interaction with core binding 
factor β (CBFβ), it modulates the activity of the RUNX 
family of transcription factors (Johnson et al., 2012).
 Small molecule inhibitors can regulate chondrogenesis 
by blocking key receptors or signalling pathways. As 
a nuclear receptor, retinoic acid receptor β (RARβ) is 
down-regulated significantly during chondrogenesis. The 
synthetic inhibitor (LE135) enhances chondrogenesis while 
inhibiting hypertrophic differentiation (Kafienah et al., 
2007). Another small molecule inhibitor, dorsomorphin, 
can block Smad1/5/8 signalling, enhance chondrogenesis, 
elevate the production of collagen II and prevent 
mineralisation (Hellingman et al., 2011; Retting et al., 
2009). Inhibition of inflammatory factors can boost 
the chondrogenic differentiation capacity of MSCs 
obtained from osteoarthritis patients through inhibiting 
inflammatory stimuli-induced damage, hypertrophy and 
apoptosis (Murphy et al., 2002; Rainbow et al., 2013).
 Using a gene transfer/silencing strategy on MSCs can 
facilitate change in the complex regulatory networks of 
stem cell biology and regulate chondrogenic differentiation 
processes (Feng et al., 2008; Paik et al., 2012). For example, 
knockdown of HIF-1α by HIF-1α small interfering RNA 
(siRNA) leads to an increase in chondrogenesis (Kanichai 
et al., 2008).
 Biomaterials can facilitate chondrogenesis in multiple 
ways, including mechanical support, surface topography 
and stiffness, chemical modification and bioactivity (Bian 
et al., 2013; Lutolf et al., 2009; Wise et al., 2009; Zhang 
et al., 2014). Co-cultures of chondrocytes and MSCs 
enhance chondrogenesis due to the trophic role of MSCs 
(MSCs secrete a variety of cytokines and growth factors 
that have both paracrine and autocrine activities), which 
stimulate chondrocyte proliferation and matrix production. 
However, MSCs in co-culture conditions do not actively 
undergo chondrogenic differentiation themselves (Caplan 
and Dennis, 2006; Meretoja et al., 2012; Wu et al., 2012).
Future Perspectives
Heterogeneous differentiation of differentiated MSCs is 
one of the main challenges faced in in vitro chondrogenic 
induction and is seldom discussed. Multiple factors are 
involved in these processes, such as variance in cell-cell 
and cell-matrix adhesions, autocrine or paracrine activities, 
different subpopulations of MSCs used, individual 
cells encapsulated in biomaterials that induces different 
cellular microenvironments (such as exchange of nutrient 
and waste, oxygen gradients), etc.. High-throughput 
technologies, such as microfluidics or microfabrication, 
may be able to set up large scale production of homogeneous 
microtissues or microenvironments to circumvent this issue 
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(Jakobsen et al., 2014). Assembling pellets containing 
varying sub-phenotypes of differentiated chondrocytes 
layer-by-layer has previously been shown to mimic the 
structural properties of articular cartilage (Chen et al., 
2006). Defining subpopulations of MSCs may provide a 
good foundation; some progress in this field has been made 
(Houlihan et al., 2012). As cells only differentiate when 
they exit the cell cycle, fine-tuned cell cycles at the initial 
stages of differentiation can influence cells to differentiate 
into homogeneous phenotypes (Li et al., 2014).
 Senescence and apoptosis inherently occur during 
both embryonic development and in vitro chondrogenic 
differentiation, so regulation of these two processes 
could potentially regulate chondrogenic differentiation. 
Senescence and apoptosis synergistically prevent the 
over-growth of chondrocytes and shapes the articular 
cartilage during embryonic development (Ito and Kida, 
2000; Loeser, 2009). Senescence of bone marrow MSCs 
is associated with low proliferation activity and decline 
of stemness (Squillaro et al., 2015), which may lead to 
inferior chondrogenic differentiation efficiency (Vacanti 
et al., 2005). Efforts in hampering cell senescence during 
chondrogenic differentiation with growth factors, anti-
inflammatory drugs, antioxidants, nutrients as well as 
appropriate microenvironments such as hypoxia and 
stem cell matrices effectively improve the efficiency and 
quality of tissue-engineered cartilage in vitro and in vivo 
(Li and Pei, 2012; Rainbow et al., 2013). It is known that 
the majority of cells in pellet cultures undergo apoptosis 
(Wang et al., 2010). Apoptosis may occur due to low 
nutrient supply to cells in the centre of the pellet, hypoxia 
and subsequent cell fate. Some preconditioning steps, 
such as use of medium with high glucose, and hypoxia 
preconditioning, may be able to protect MSCs from 
undergoing the process of apoptosis (Mackay et al., 1998; 
Wang et al., 2008).
 In addition, biophysical signals are indispensable 
for successful chondrogenic differentiation. Mechanical 
properties influence phenotypes of differentiated 
chondrocytes and affect respective progenies (Yang 
et al., 2014). Oxygen tension or hypoxia can facilitate 
differentiation. MSCs can differentiate into hyaline cartilage 
chondrocytes instead of hypertrophic chondrocytes which 
is more likely to happen under current chondrogenic 
differentiation protocols (Leijten et al., 2014). Premature 
and unstable phenotypes of differentiated chondrocytes 
pose challenges for potential clinical use and lead to 
inferior quality of regenerated cartilage (Pelttari et 
al., 2006). Mimicking embryonic articular cartilage 
formation instead of embryonic chondrogenesis can 
assist bioengineers in overcoming this challenge, which 
means that temporal regulation of multiple factors may 
be required. For example, decreased Wnt, hedgehog and 
BMP signalling and specification of GDF-5 expression 
are of great importance for the homeostasis of articular 
chondrocytes (Bobacz et al., 2008; Leijten et al., 2012). 
Previous studies have shown that over expression of 
GDF-5 led to the unsuccessful differentiation of articular 
chondrocytes (Feng et al., 2008). However, the role of GDF-
5 in embryonic arthrogenesis and postnatal development 
is not entirely clear. From our viewpoint, hypertrophy 
will not pose challenges to chondrogenic differentiation 
if optimised protocols can further differentiate stem cells 
into articular chondrocytes and maintain their classic 
phenotypes.
 Temporally fine-tuning chondrogenic differentiation 
medium can profoundly enhance differentiation efficiency. 
Chondrogenic differentiation medium is involved in 
administering TGF-β and other factors throughout 
the entire culture period (Johnstone et al., 1998). 
Previously, multiple factors induced step-wise mesoderm 
differentiation and subsequent chondrogenesis through 
mimicking embryonic chondrogenesis (Oldershaw et al., 
2010). The sequential addition of growth factors may be 
able to improve chondrogenesis based on gene expression 
of cell surface receptors and effectiveness of growth 
factors; withdrawal of the growth factors after nine days 
improves chondrogenesis (Handorf and Li, 2014). Apart 
from the addition of growth factors, inhibition of specific 
cell signalling pathways may also enhance chondrogenesis, 
such as the Smad1/5/8 signalling inhibitor dorsomorphin 
(Hellingman et al., 2011; Retting et al., 2009) or Wnt 
inhibitors [Gremlin 1, frizzled-related protein (FRP) or 
dickkopf (Dkk-1)] (Leijten et al., 2012).
 Use of mathematical models can assist researchers 
in regulating chondrogenic differentiation. A “seesaw 
model” describes a balance between mesendodermal 
and ectodermal specification of pluripotency (Shu and 
Deng, 2013) and the cross-talk between genetics and 
epigenetics (Leijten et al., 2014). The lineage specifiers 
of mesendodermal and ectodermal are considered as 
pluripotency rivals. However, these lineage specifiers have 
shown to facilitate reprogramming of differentiated cells 
to the pluripotent state when a balance is achieved.
Summary
MSCs are a promising source of precursor cells, which are 
widely used in cartilage tissue engineering. By reviewing 
the process of cartilage development and the constituents of 
existing medium formulations for promoting chondrogenic 
differentiation, we have identified potential factors to 
generate a more stable and reliable hyaline cartilage 
in vitro. Cellular metabolic status, especially glucose 
metabolism and inhibition of inflammatory factors, need 
to be considered when trying to inhibit cell senescence 
and apoptosis. The combination and concentration of 
growth factors, the timing of the application of biochemical 
components and proper biophysical stimuli during cell 
culture needs further optimisation to achieve desirable 
differentiation outcomes.
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